Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has collaborated with B. Braun Medical Inc., located in Bethlehem, PA, who recently launched its prefilled syringe of Heparin Sodium Injection, USP utilizing Schreiner MediPharm’s label- integrated Needle-Trap system to the U.S. market.
According to B. Braun, this is the first prefilled heparin syringe with an integrated needle protection device approved by the U.S. Food and Drug Administration (FDA).
In the United States, syringes should be used with safety devices to protect healthcare staff against the risk of needlestick injuries. B. Braun Medical was looking for an efficient and safe needle protection solution for its prefilled Heparin Sodium Injection and found it in Needle-Trap from Schreiner MediPharm.
The Needle-Trap system is an internationally established solution that complies with the U.S. NIOSH requirements for safe instruments and has been awarded 510(k) Pre- Market Notification by the FDA for marketing in the United States.
“Clinical staff benefit from reliable protection against needlestick injuries because Needle-Trap’s activation is easy and irreversible. It is intuitive to use and requires no change in injection technique,” says Gene Dul, President of Schreiner MediPharm U.S.
Needle-Trap is the only label-based needle protection system on the market. The plastic needle trap is an integral component of the marking label and serves to secure the needle after the injection has been performed.
Due to its special construction, Needle- Trap can easily and cost-efficiently be integrated into existing pharmaceutical production processes. It requires only minor modifications of the application systems, no changes to secondary packaging, and minimal space during shipping, storage and disposal.
“Our products are designed to increase patient and clinician safety, while reducing medication errors and improving dosage accuracy and workflows. Obviously, efficient and economical manufacturing are equally important. Collaborating with Schreiner MediPharm allowed us to meet those needs,” says Leigh Nickens, Director of Marketing, Fluid Therapy and Injectable Drugs at B. Braun.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.
Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.
Combined expertise: Schreiner MediPharm and Edelmann Group develop demo version of a smart packaging solution
Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features.
A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healthcare staff from accidently activating the mechanism too early.
Schreiner MediPharm introduces BitSecure Mobile, a digital counterfeiting detection solution
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced BitSecure Mobile, a digital counterfeiting detection solution to help fight illegal trade in counterfeit medicines.
Schreiner MediPharm develops multifunctional covert-hologram seal for tamper protection
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection. The seal, which features an irreversible, holographic effect, complies with the Falsified Medicines Directive 2011/62/EU that will be enforced from February 2019.
Schreiner MediPharm develops smart blister pack for clinical trial
Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, working in conjunction with the Dutch technology company ECCT (Experts in Communications & Connectivity Technology), has developed a smart blister pack for a global pharmaceutical corporation to enhance medication adherence by clinical trial participants.
Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility
Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.
Schreiner MediPharm develops multi-functional labels for SHL Medical Auto Injectors
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has developed specialty labels for demo devices of various SHL Medical auto injector models in which safety and patient ease of use are paramount. .
Schreiner Medipharm develops innovative label with self-lifting starter tab for small vials
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has introduced a new version of its Pharma-Comb SL (Self-Lifting) label with a special starter tab.
Pharma-Tac Plus Label from Schreiner MediPharm wins first place in North American Tag and Label Manufacturers Institute International Competition
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has been recognized with a first place award for its Pharma-Tac Plus hanging label.
- Isabel Thomas
- Brand Launch
- Created 30 Apr 2019
- Modified 30 Apr 2019
- Hits 477